EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sinohealth Holdings's enterprise value is HK$646.1 Mil.
Sinohealth Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$137.9 Mil. Therefore, Sinohealth Holdings's EV-to-EBITDA for today is 4.68.
The historical rank and industry rank for Sinohealth Holdings's EV-to-EBITDA or its related term are showing as below:
HKSE:02361'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.48 Med: 13.38 Max: 22.94
Current: 4.69
During the past 6 years, the highest EV-to-EBITDA of Sinohealth Holdings was 22.94. The lowest was 2.48. And the median was 13.38.
HKSE:02361's EV-to-EBITDA is ranked better than 87% of 500
companies
in the Healthcare Providers & Services industry
Industry Median: 11.93
vs HKSE:02361: 4.69
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Sinohealth Holdings EV-to-EBITDA Historical Data
The historical data trend for Sinohealth Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinohealth Holdings's EV-to-EBITDA
For the Health Information Services subindustry, Sinohealth Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinohealth Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sinohealth Holdings's EV-to-EBITDA falls into.
Sinohealth Holdings's current Enterprise Value is HK$646.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$137.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sinohealth Holdings's PE Ratio (TTM) for today is calculated as:
Sinohealth Holdings's share price for today is HK$3.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.289.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Sinohealth Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02361 has been successfully added to your 